secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001493152-24-010600
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow gets CMS confirmation that IHEEZO is separately payable in physician office setting
--------------------------------------------------------------------------------

- CMS confirmed IHEEZO's J-Code 2403 will be included in April 2024 quarterly ASP drug pricing file.
- Separate payment for IHEEZO in physician offices applies under Medicare Part B beginning April 2024.
- This regulatory milestone may improve IHEEZO adoption and reimbursement for Harrow (HROW).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/0001493152-24-010600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224010600/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer